Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Health Velocity Capital is to be the preferred innovation partner of entrepreneurs and investors working toward the common goal of a high quality, customer-friendly, affordable and sustainable healthcare system.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2021 | Torch Technology | Venture Round | 21M |
6/2021 | Hospital IQ | Series C | 0 |
11/2019 | Contessa | Series D | 32.5M |
5/2022 | Greater Good Health | Seed Round | 0 |
2/2021 | Array Behavioral Care | Series B | 24M |
1/2023 | Array Behavioral Care | Equity | 25M |
6/2023 | Octave | Series C | 0 |
3/2022 | Compass Surgical Partners | Venture Round | - |
1/2019 | Jvion | Private Equity Round | 92M |
8/2019 | IVX Health | Equity | 22.5M |
3/2023 | Clever Care Health Plan Inc. | Series C | 0 |
5/2021 | Octave | Series B | 20M |
10/2022 | HealthJoy | Series D | 0 |
12/2022 | Fortified Health Security | Venture Round | - |
7/2020 | Lemonaid Health | Series B | 0 |
9/2021 | Clever Care Health Plan Inc. | Series B | 71M |
3/2022 | Rialtic | Series A | 0 |
1/2023 | ShiftKey | Private Equity Round | 300M |
9/2021 | IVX Health | Series F | 0 |
11/2020 | Well Health | Series C | 0 |
8/2018 | MDLIVE | Venture Round | 50M |
2/2020 | HealthJoy | Series C | 30M |
4/2016 | OnShift | Series D | 0 |
1/2020 | Zipari | Series B | 0 |
12/2021 | Prolucent Health | Series A | 11.5M |
4/2018 | Contessa | Series C | 16.3M |
5/2022 | Greater Good Health | Seed Round | 10M |
5/2022 | Greater Good Health | Series A | 0 |
3/2022 | Compass Surgical Partners | Venture Round | - |
3/2022 | Rialtic | Series A | 0 |
12/2021 | Prolucent Health | Series A | 0 |
9/2021 | Clever Care Health Plan Inc. | Series B | 0 |
9/2021 | IVX Health | Series F | 0 |
6/2021 | Hospital IQ | Series C | 0 |
5/2021 | Octave | Series B | 0 |
2/2021 | Array Behavioral Care | Series B | 0 |
11/2020 | Well Health | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|